Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Aisha Walker, PhD
Researcher Assistant Professor of Medicine
Division of Pulmonary,
Allergy and Critical Care Medicine
Vascular Medicine Institute
University of Pittsburgh
E1226-0A BST
200 Lothrop Street
Pittsburgh, Pennsylvania, United States
Dr. Walker is a Research Assistant Professor in the Vascular Medicine Institute at University of Pittsburgh. Dr. Walker is currently a Sickle Cell Scholar at Pitt. Her basic and translational research projects continue to investigate mechanisms related to pharmacologic therapies for sickle cell disease.
Dr. Walker’s primary research goal is to identify novel therapeutic strategies for the treatment of sickle cell disease (SCD). Her current projects are focused on identifying cellular and molecular modulators that mediate efficacy and toxicity of hydroxyurea, which is currently the only FDA approved drug for SCD. Dr. Walker’s work was the first to identify specific cell membrane transporters and microRNAs associated with the pharmacokinetics and clinical outcomes of hydroxyurea.
+myBinderRelated Content
-
These patients had sickle-cell disease. Experimental therapies might have cured themScientists have long known what causes s...
-
Cecelia R. Valrie, PhDDr. Cecelia Valrie is a developmental-he...
-
Acute Care Utilization in Pediatric Sickle Cell Disease and Sickle Cell Trait in the USA: Prevalence, Temporal Trend...The objective of this study was to analy...
-
Discovery could help treatments for sickle cell diseaseResearch team establishes biomarkers for...
-
Bioverativ and Sangamo announce FDA acceptance of IND application for gene-edited cell therapy BIVV003 to treat sick...Bioverativ Inc., a Sanofi company dedi...
-
Unanticipated consequences identified after implementation of a pediatric emergency department (PED)-based intranasa...Background: The 2014 National Heart Lun...
-
At 16, She’s a Pioneer in the Fight to Cure Sickle Cell DiseaseHelen Obando, a shy slip of a girl, lay ...
